// App-Quantinova.ai

P2-02-01 : In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcome

Researchers

Presenter

  • Kasimir-Bauer S

Principal Investigators

  • Bittner A-K

  • Aktas B

  • Hauch S

  • Kimmig R

  • Hoffmann O

Medical Centers

  • University Hospital of Essen, Essen, Germany

Locations

  • Germany

Companies

  • Qiagen Hannover GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • AKT Serine/Threonine Kinase 2

  • Aldehyde dehydrogenase 1

  • Cancer antigen 15-3

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Circulating tumor cells

  • Progesterone receptor

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

  • Solute Carrier Family 22 Member 3

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved